Get the Stockscreener App
11.00
0.46%
0.05
After Hours:
10.85
-0.15
-1.36%
Immatics N V stock is traded at $11.00, with a volume of 322.18K.
It is up +0.46% in the last 24 hours and up +19.05% over the past month.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$10.95
Open:
$10.89
24h Volume:
322.18K
Relative Volume:
0.74
Market Cap:
$1.48B
Revenue:
$53.99M
Net Income/Loss:
$-222.30M
P/E Ratio:
-6.0553
EPS:
-1.8166
Net Cash Flow:
$-213.50M
1W Performance:
+4.46%
1M Performance:
+19.05%
6M Performance:
+1.57%
1Y Performance:
+151.72%
1-Day Range:
$10.81
$11.10
1-Week Range:
$10.35
$11.10
52-Week Range:
$3.94
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
11.00 | 1.47B | 53.99M | -222.30M | -213.50M | -1.8166 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Resumed | Jefferies | Buy |
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
ETF Watch: Can Immatics NV Equity Warrant generate free cash flow2026 Sentiment & Weekly Stock Breakout Alerts - baoquankhu1.vn
Exit Recap: Is Immatics NV currently under institutional pressure2026 Momentum & Capital Protection Trade Alerts - baoquankhu1.vn
Take Profit: Is Immatics NV forming a breakout pattern2026 News Drivers & Weekly High Conviction Ideas - baoquankhu1.vn
Risk Analysis: Should I invest in Immatics NV Equity Warrant before earningsEarnings Beat & Accurate Entry/Exit Alerts - baoquankhu1.vn
(IMTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
SG Americas Securities LLC Makes New Investment in Immatics N.V. $IMTX - MarketBeat
IMTX Technical Analysis & Stock Price Forecast - Intellectia AI
Is Immatics (IMTX) Building a PRAME-Focused Platform or Stretching Its Oncology Ambitions Too Thin? - Sahm
Aug Technicals: Should I invest in Immatics NV Equity Warrant before earnings2026 PostEarnings & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Retail Trends: Should you buy the dip on Immatics NV2026 Decliners & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Reactions: What is the target price for Immatics NV stock2026 Movers & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Immatics NV (IMTX) seeing strong enrollment in a key phase 3 trial of drug candidate - MSN
Earnings Miss: Is Immatics NV a cyclical or defensive stock2026 Price Swings & Real-Time Volume Spike Alerts - baoquankhu1.vn
IMTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Earnings Recap: Will Immatics NV Equity Warrant benefit from government policyWeekly Gains Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Bear Alert: Is Immatics NV stock risky to hold now2026 Technicals & Stepwise Swing Trade Plans - baoquankhu1.vn
Immatics N.V. Ordinary Shares (IMTX) Stock Price Today & Analysis - Gotrade
Aug Closing: Does Immatics NV stock have upside surprise potentialTrade Exit Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Panic Selling: How is Immatics NV Equity Warrant managing supply chain issues2026 Setups & Daily Profit Focused Stock Screening - baoquankhu1.vn
Aug Closing: What is Immatics NV Equity Warrants market position2026 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
Breakouts Watch: Is Immatics NV forming a breakout pattern2026 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Immatics price target raised to $17 from $14 at BofA - MSN
(IMTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com
Immatics NV stock advances on promising TCR-T cell therapy data amid biotech rally - AD HOC NEWS
Fund Flows: Will Immatics NV Equity Warrant outperform its industry peers2026 Buyback Activity & Risk Controlled Swing Alerts - baoquankhu1.vn
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX) - MSN
IMTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Immatics (IMTX) Expected to Announce Earnings on Thursday - MarketBeat
Immatics (IMTX) Chief Development Officer files Form 3 detailing equity - Stock Titan
Immatics (IMTX) CMO Cedrik Britten reports option, RSU and share holdings - Stock Titan
Immatics (IMTX) General Counsel reports stock options and RSUs - Stock Titan
[Form 3] Immatics N.V. Initial Statemen... - Stock Titan
Immatics (IMTX) CEO reports options, RSUs and share holdings - Stock Titan
Immatics (IMTX) director reports sizeable stock option holdings - Stock Titan
Immatics (IMTX) CFO reports 350,000 stock options holding - Stock Titan
Immatics N.V. (IMTX) director Eliot Forster details stock option holdings - Stock Titan
Immatics (IMTX) Chief People Officer reports 211,000 share options on Form 3 - Stock Titan
Immatics (IMTX) director discloses existing stock option grants - Stock Titan
Immatics (IMTX) director discloses multiple long-dated stock options - Stock Titan
Immatics (IMTX) director reports multiple long-dated stock option grants - Stock Titan
Immatics (IMTX) COO details stock options, RSUs and share holdings - Stock Titan
Immatics (IMTX) CBO details stock option and RSU positions - Stock Titan
Immatics (IMTX) director Chambre details ordinary share and option stakes - Stock Titan
Immatics (IMTX) director Michael G. Atieh reports stock option positions - Stock Titan
Immatics (IMTX) Chief Innovation Officer discloses option and RSU stakes - Stock Titan
Why Immatics (IMTX) Is Down 6.4% After Deepening Losses And Highlighting SUPRAME Phase 3 Progress - simplywall.st
Immatics (IMTX) director entities disclose indirect share and option stakes - Stock Titan
Aug PreEarnings: What is the target price for Immatics NV stockWeekly Trading Summary & Verified Technical Signals - baoquankhu1.vn
Risk Check: Is Immatics NV a defensive stock2026 Winners & Losers & Reliable Momentum Entry Alerts - baoquankhu1.vn
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):